8-K

Company

Centessa Pharmaceuticals plc

Filed

March 24, 2025

Period of Report

March 24, 2025

Accession Number

0001847903-25-000049

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →